Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1980
Inherited 7S immunoglobulin deficiency in chickens: presence of suppressor T cells that suppress synthesis of 7S immunoglobulin but not IgMT C Chanh, A A Benedict, L Q Tam, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987
Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptideE M Zhou, T C Chanh, G R Dreesman, et al.Lancet (London, England)|November 7, 1987
Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccineA G Dalgleish, B J Thomson, T C Chanh, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate speciesR Attanasio, J S Allan, S A Anderson, et al.Cellular Immunology|August 1, 1988
Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptidesR Cauda, M Tumbarello, L Ortona, et al.Journal of Medical Primatology|September 1, 1994
Production and characterization of murine monoclonal antibodies specific for baboon IgG heavy and light chain epitopesM H Shearer, H B Jenson, K D Carey, et al.Journal of Medicinal Chemistry|July 24, 1992
HIV-1 neutralization and tumor cell proliferation inhibition in vitro by simplified analogues of pyrido[4,3,2-mn]thiazolo[5,4-b]acridine marine alkaloidsI B Taraporewala, J W Cessac, T C Chanh, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
A rapid, large scale purification procedure for gibbon interleukin 2L E Henderson, J F Hewetson, R F Hopkins, et al.Natural Immunity and Cell Growth Regulation|January 1, 1990
Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptidesR Cauda, M Tumbarello, L Ortona, et al.Vaccine|January 1, 1993
Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibodyJ F Hewetson, V R Rivera, D A Creasia, et al.Pageof 6